EARNINGS DESK$JNJJohnson & JohnsonOpen ticker analysis →
Johnson & Johnson reported $0.09 a share against $2.07 a share analysts expected for 2026Q3. A miss puts the burden on guidance to explain what went wrong and when it gets fixed.
What happened
The company reported $0.09 a share versus an estimate of $2.07 a share, a 95.7% miss.
Revenue was $25.4B against $25.4B expected, 0.1% ahead.
$JNJ was at $250.51, down 5% on the day.
Why it matters
Analysts expect a profit of $2.07 a share, so the bar is about growth and margins rather than survival.
For scale, Johnson & Johnson is a mega-cap pharmaceutical preparations company valued near $635.6B, so it takes serious money to move the stock, which is what makes signals like this one worth tracking.
Earnings and revenue disagree, one ahead and one behind, so the quality of the quarter is the real debate.
Implied volatility sits in the 66th percentile of its past year, so options are not especially expensive heading into the print.
Zooming out, $JNJ has been in a mostly sideways stretch, down 1% over the past 20 sessions, and it trades below its 20-day average of $264.56, near the bottom of that range between $251.17 and $281.07.
The numbers
| Report date | 2026-10-13 |
|---|---|
| Timing | Before the bell |
| Period | 2026Q3 |
| EPS actual | $0.09 |
| EPS estimate | $2.07 |
| EPS surprise | -95.7% |
| Revenue actual | $25.4B |
| Revenue estimate | $25.4B |
| IV percentile | 66th |
| Stock price | $250.51 |
| 39-session range | $251.17, $281.07 |
| 20-day average price | $264.56 |
| 20-session change | -1.0% |
Three ways this could play out
Bullish continuation
Guidance backs up the numbers and $JNJ clears $281.07, the top of its recent range. That puts the stock above its recent range and invites analysts to raise targets.
Bearish rejection
The call raises doubts about the next quarter and $JNJ loses $237.98, turning the report into a reason to sell.
Neutral stabilization
Results land close to expectations and $JNJ settles between $237.98 and $281.07 while volatility drains out of the options.
What to watch next
- Guidance for the next quarter and full year, usually the biggest driver of the reaction.
- Margins, which show whether growth is profitable or bought.
- The day-two move. Earnings gaps that hold into the second session tend to stick.
- $251.17 and $281.07: the recent range the reaction has to break.
